Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Debt / NOTE 2.000% 3/1
-
Market price (% of par)
-
88.89%
-
Total 13F principal
-
$289,012,700
-
Principal change
-
-$21,077,300
-
Total reported market value
-
$257,820,283
-
Number of holders
-
39
-
Value change
-
-$20,288,035
-
Number of buys
-
19
-
Number of sells
-
16
Institutional Holders of AMPHASTAR PHARMACEUTICALS IN - NOTE 2.000% 3/1 as of Q1 2025
As of 31 Mar 2025,
AMPHASTAR PHARMACEUTICALS IN - NOTE 2.000% 3/1 was held by
39 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$289,012,700
in principal (par value) of the bond.
The largest 10 bondholders included
Linden Advisors LP, Wellesley Asset Management, CAMDEN ASSET MANAGEMENT L P /CA, MACKAY SHIELDS LLC, Empyrean Capital Partners, LP, Calamos Advisors LLC, WOLVERINE ASSET MANAGEMENT LLC, SILVERBACK ASSET MANAGEMENT LLC, MORGAN STANLEY, and WELLS FARGO & COMPANY/MN.
This page lists
39
institutional bondholders reporting positions
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.